Zymeworks agrees to buy Theravance Biopharma for $929m
Zymeworks agrees to buy Theravance Biopharma for $929m
Zymeworks agrees to buy Theravance Biopharma for $929m
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.